IMPORTANT NOTE. We strongly recommend that you consult your doctor for proper advice before using any medications, including vitamins, supplements, herbals and products for the skin.
Brand Name, Dosage Format and Strength
Funzela 50 mg Tablet
Aminoglycoside, Cephalosporin, Chloramphenicol, Lincosamide, Macrolide, Penicillin, Penicillin + Beta lactamase Inhibitor , Penicillinase-resistant isoxazolylpenicillin, Penicillin; Beta-lactam + Beta-lactamase Inhibitor, Quinolone, Sulfonamide + Folate Inhibitor, Tetracycline, Triazole Antibiotic, Immunostimulant, Neuraminidase Inhibitor
WARNINGS AND PRECAUTIONS
- Serious adverse hepatic effects have been reported with fluconazole. Although these are rare, these should be considered when giving fluconazole therapy. If signs and symptoms of liver disease develop, treatment should be discontinued immediately; if abnormal liver function tests occur, the patient should be carefully monitored for the possibility of more severe liver injury.
- Overgrowth of nonsusceptible strains of Candida has been reported in some patients receiving fluconazole. When this occurs, patients may require an alternative anti-fungal therapy.
- Anaphylaxis has occurred rarely in patients taking fluconazole.
- Rare but serious exfoliative skin disorders such as SJS and toxic epidermal necrolysis have been reported during treatment with fluconazole which rarely resulted in a fatal outcome in patients with serious underlying diseases (predominantly AIDS & malignancy). It is recommended that in patients with superficial fungal infection, fluconazole treatment be discontinued at the first sign of rash. Patients with serious underlying disease who develop rashes should be closely observed and fluconazole treatment should be discontinued when bullous lesions or erythema multiforme progresses.